Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...

Rezdiffra made headlines last year as the first drug cleared to treat MASH, with the FDA specifically clearing the drug in patients with stages F2 and F3 non-cirrhotic MASH. As the launch gains ...

Heads up Monster Hunter Wilds players, a new limited-time event is coming tomorrow! Titled the "Festival of Accord: Blossomdance", players will be able to hang around a fancy new gathering hub ...

the studio is once again calling Village Roadshow Studios home for its latest monster mash. The production marks the fourth Monsterverse title to shoot in the northeastern Australian state ...

GameSpot may get a commission from retail offers. Capcom has found some players are cheating in certain Monster Hunter Wilds quests by modifying the game to output higher rewards, and has warned ...

Spoiling the party was the high-flying acrobatics of Cleveland goalie Jet Greaves and a Monster effort by Dylan Gambrell, who potted a pair to pace the visitors win. Greaves antics between the ...

were else to go! but the super swing-bit orchestra show! for all your Swingin' needs ~ Taking small breaks here and there from my big job project and making something purely for the fun of it.

Her work has previously appeared at NPR, Wired, and The Verge. First announced during the Monster Hunter Wilds showcase in March, this event will be one of the first big changes coming to the game ...

A monster who raped and sexually assaulted three children has been jailed for 27 years. Stephen Sanders of Raleigh Avenue, Torquay, was found guilty by a jury of three indecent assaults ...

Get Instant Summarized Text (Gist) A bifunctional exosome-based drug delivery system was developed to target metabolic dysfunction-associated steatohepatitis (MASH). By engineering exosomes to ...

(RTTNews) - Akero Therapeutics (AKRO) unveiled new data from its Phase 2b SYMMETRY trial highlighting the potential of efruxifermin - EFX to reverse fibrosis in patients with compensated cirrhosis ...